According to Abeona Therapeutics 's latest financial reports the company's total assets are $64 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $64.21 M | -19.31% |
2021-12-31 | $79.58 M | -47.36% |
2020-12-31 | $0.15 B | -32.31% |
2019-12-31 | $0.22 B | 28.09% |
2018-12-31 | $0.17 B | -2.44% |
2017-12-31 | $0.17 B | 60.97% |
2016-12-31 | $0.11 B | 38.73% |
2015-12-31 | $80.05 M | 382.78% |
2014-12-31 | $16.58 M | 2605.06% |
2013-12-31 | $0.61 M | -64.57% |
2012-12-31 | $1.73 M | -54.29% |
2011-12-31 | $3.78 M | -56.85% |
2010-12-31 | $8.77 M | 454.07% |
2009-12-31 | $1.58 M | -62.05% |
2008-12-31 | $4.17 M | -54.41% |
2007-12-31 | $9.14 M | 42.37% |
2006-12-31 | $6.42 M | -10.91% |
2005-12-31 | $7.21 M | -34.96% |
2004-12-31 | $11.09 M | -6.1% |
2003-12-31 | $11.81 M | -39.39% |
2002-12-31 | $19.48 M | -23.54% |
2001-12-31 | $25.48 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Merck MRK | $106.67 B | 166,574.48% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $2.16 B | 3,279.86% | ๐ฎ๐ฑ Israel |